SandboxAQ and Mayo Clinic Join Forces on Cutting-Edge Cardiac Diagnostics

Harnessing AI and Magnetocardiography to Transform Heart Disease Detection and Save Lives

In a groundbreaking move to combat cardiovascular diseases—the leading cause of death worldwide—SandboxAQ has announced a strategic collaboration with the Mayo Clinic to explore the potential of advanced AI-powered magnetocardiography (MCG) technology. This partnership aims to significantly enhance the accuracy and efficiency of cardiac diagnostics, offering hope for millions of patients globally.

The collaboration centers around the deployment of SandboxAQ's innovative MCG imaging system, known as CardiAQ. This state-of-the-art device, equipped with magnetic sensors and sophisticated AI algorithms, promises to revolutionize cardiac diagnostics by providing rapid, radiation-free visualization of the heart’s magnetic signals. Unlike traditional methods, CardiAQ’s mobile, non-invasive approach offers a safer and more accessible alternative for heart disease detection.

Mayo Clinic researchers are set to begin clinical trials of CardiAQ in a study spanning 2024 and 2025 at their Rochester, MN, facility. The study will investigate the correlation between CardiAQ’s MCG readings and angiography findings, potentially paving the way for a new standard in cardiac care.

CardiAQ’s technology stands out for its ability to detect minute variations in the magnetic field surrounding the heart, capturing pristine electrical conduction activities with each heartbeat. This could enable healthcare providers to identify abnormal patterns and other indicators of cardiac disease more effectively, ultimately leading to improved patient outcomes and a reduction in mortality rates.

As the world grapples with the ongoing challenge of cardiovascular disease, the collaboration between SandboxAQ and Mayo Clinic represents a beacon of innovation and hope, setting the stage for a new era in cardiac diagnostics.